Shenzhen Geno-Immune Medical Institute ^Company

Shenzhen Genoimmune Medical Institute is founded by Shenzhen Government in 2015 and come into construction in 2016.The key function and goal of this institute are to provide contracted research & technical services for individually cell-based immunotherapy. The research team consists of many experienced scientists with expertise of clinical & translational research as headed by Dr. Lung-Ji Chang. The advanced lentiviral vector technologies associated with CAR-T and Gene therapy will be our core competence to develop various therapeutic solutions for cancers and other genetic diseases.